WO2005028661A1 - カロテノイド化合物の製造方法 - Google Patents
カロテノイド化合物の製造方法 Download PDFInfo
- Publication number
- WO2005028661A1 WO2005028661A1 PCT/JP2004/013033 JP2004013033W WO2005028661A1 WO 2005028661 A1 WO2005028661 A1 WO 2005028661A1 JP 2004013033 W JP2004013033 W JP 2004013033W WO 2005028661 A1 WO2005028661 A1 WO 2005028661A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- zeaxanthin
- strain
- carotenoid
- ratio
- mass
- Prior art date
Links
- 235000021466 carotenoid Nutrition 0.000 title claims abstract description 167
- 238000000034 method Methods 0.000 title claims abstract description 69
- -1 carotenoid compound Chemical class 0.000 title claims description 95
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 claims abstract description 121
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 claims abstract description 121
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 claims abstract description 121
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 121
- 239000001775 zeaxanthin Substances 0.000 claims abstract description 121
- 235000010930 zeaxanthin Nutrition 0.000 claims abstract description 121
- 229940043269 zeaxanthin Drugs 0.000 claims abstract description 121
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 claims abstract description 120
- 150000001747 carotenoids Chemical class 0.000 claims abstract description 106
- 244000005700 microbiome Species 0.000 claims abstract description 102
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 claims abstract description 79
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 claims abstract description 78
- 239000001751 lycopene Substances 0.000 claims abstract description 78
- 235000012661 lycopene Nutrition 0.000 claims abstract description 78
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 claims abstract description 78
- 229960004999 lycopene Drugs 0.000 claims abstract description 78
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 claims abstract description 78
- 239000000203 mixture Substances 0.000 claims abstract description 39
- 108020004465 16S ribosomal RNA Proteins 0.000 claims abstract description 12
- 238000012258 culturing Methods 0.000 claims abstract description 10
- QXNWZXMBUKUYMD-ITUXNECMSA-N 4-keto-beta-carotene Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C QXNWZXMBUKUYMD-ITUXNECMSA-N 0.000 claims description 116
- FDSDTBUPSURDBL-LOFNIBRQSA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-LOFNIBRQSA-N 0.000 claims description 114
- 238000004519 manufacturing process Methods 0.000 claims description 83
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 claims description 77
- 235000013793 astaxanthin Nutrition 0.000 claims description 77
- 239000001168 astaxanthin Substances 0.000 claims description 77
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 claims description 77
- 229940022405 astaxanthin Drugs 0.000 claims description 77
- OOUTWVMJGMVRQF-DOYZGLONSA-N Phoenicoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)C(=O)CCC2(C)C OOUTWVMJGMVRQF-DOYZGLONSA-N 0.000 claims description 64
- JUVIOZPCNVVQFO-HBGVWJBISA-N rotenone Chemical compound O([C@H](CC1=C2O3)C(C)=C)C1=CC=C2C(=O)[C@@H]1[C@H]3COC2=C1C=C(OC)C(OC)=C2 JUVIOZPCNVVQFO-HBGVWJBISA-N 0.000 claims description 60
- 235000012682 canthaxanthin Nutrition 0.000 claims description 58
- 235000006932 echinenone Nutrition 0.000 claims description 58
- YXPMCBGFLULSGQ-YHEDCBSUSA-N echinenone Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(=O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C YXPMCBGFLULSGQ-YHEDCBSUSA-N 0.000 claims description 58
- 239000001659 canthaxanthin Substances 0.000 claims description 57
- 229940008033 canthaxanthin Drugs 0.000 claims description 57
- YECXHLPYMXGEBI-DOYZGLONSA-N Adonixanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C YECXHLPYMXGEBI-DOYZGLONSA-N 0.000 claims description 51
- YECXHLPYMXGEBI-ZNQVSPAOSA-N adonixanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C[C@@H](O)CC1(C)C YECXHLPYMXGEBI-ZNQVSPAOSA-N 0.000 claims description 51
- 230000035772 mutation Effects 0.000 claims description 41
- 239000004212 Cryptoxanthin Substances 0.000 claims description 39
- DFNMSBYEEKBETA-JZLJSYQFSA-N 3-Hydroxyechinenone Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C DFNMSBYEEKBETA-JZLJSYQFSA-N 0.000 claims description 20
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 claims description 20
- DFNMSBYEEKBETA-FXGCUYOLSA-N rac-3-Hydroxyechinenon Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)C(=O)C(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DFNMSBYEEKBETA-FXGCUYOLSA-N 0.000 claims description 20
- 239000002773 nucleotide Substances 0.000 claims description 14
- 125000003729 nucleotide group Chemical group 0.000 claims description 14
- DMASLKHVQRHNES-UPOGUZCLSA-N (3R)-beta,beta-caroten-3-ol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C DMASLKHVQRHNES-UPOGUZCLSA-N 0.000 claims description 13
- 229940075420 xanthine Drugs 0.000 claims description 11
- 235000002360 beta-cryptoxanthin Nutrition 0.000 claims description 10
- DMASLKHVQRHNES-ITUXNECMSA-N beta-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CCCC2(C)C DMASLKHVQRHNES-ITUXNECMSA-N 0.000 claims description 10
- NBZANZVJRKXVBH-ITUXNECMSA-N all-trans-alpha-cryptoxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CCCC2(C)C)C NBZANZVJRKXVBH-ITUXNECMSA-N 0.000 claims description 9
- 239000011774 beta-cryptoxanthin Substances 0.000 claims description 9
- 150000001875 compounds Chemical class 0.000 claims description 9
- 239000007787 solid Substances 0.000 claims description 9
- OOUTWVMJGMVRQF-NWYYEFBESA-N Phoenicoxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C OOUTWVMJGMVRQF-NWYYEFBESA-N 0.000 claims description 7
- 238000000605 extraction Methods 0.000 claims description 7
- 231100000350 mutagenesis Toxicity 0.000 claims description 6
- 238000002703 mutagenesis Methods 0.000 claims description 5
- 208000007442 rickets Diseases 0.000 claims description 3
- 238000000855 fermentation Methods 0.000 claims 1
- 230000004151 fermentation Effects 0.000 claims 1
- 235000013734 beta-carotene Nutrition 0.000 abstract description 17
- 239000011648 beta-carotene Substances 0.000 abstract description 17
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 abstract description 17
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 abstract description 16
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 abstract description 16
- 229960002747 betacarotene Drugs 0.000 abstract description 16
- 238000003306 harvesting Methods 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 57
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 28
- 238000004458 analytical method Methods 0.000 description 27
- 238000001514 detection method Methods 0.000 description 24
- 238000004128 high performance liquid chromatography Methods 0.000 description 17
- 239000000047 product Substances 0.000 description 16
- 238000011282 treatment Methods 0.000 description 16
- 241000894006 Bacteria Species 0.000 description 14
- 229910052697 platinum Inorganic materials 0.000 description 14
- 102000008109 Mixed Function Oxygenases Human genes 0.000 description 8
- 108010074633 Mixed Function Oxygenases Proteins 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- PLUBXMRUUVWRLT-UHFFFAOYSA-N Ethyl methanesulfonate Chemical compound CCOS(C)(=O)=O PLUBXMRUUVWRLT-UHFFFAOYSA-N 0.000 description 6
- 230000002950 deficient Effects 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000002537 cosmetic Substances 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 241000195493 Cryptophyta Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 4
- 229930006000 Sucrose Natural products 0.000 description 4
- 240000008042 Zea mays Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 4
- 238000013019 agitation Methods 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- 230000001747 exhibiting effect Effects 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000005720 sucrose Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 244000000626 Daucus carota Species 0.000 description 3
- 235000002767 Daucus carota Nutrition 0.000 description 3
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000001888 Peptone Substances 0.000 description 3
- 108010080698 Peptones Proteins 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 240000003768 Solanum lycopersicum Species 0.000 description 3
- 238000005273 aeration Methods 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 238000010170 biological method Methods 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000012136 culture method Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 230000001678 irradiating effect Effects 0.000 description 3
- 239000003471 mutagenic agent Substances 0.000 description 3
- 231100000707 mutagenic chemical Toxicity 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000004816 paper chromatography Methods 0.000 description 3
- 235000019319 peptone Nutrition 0.000 description 3
- 238000000053 physical method Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 238000000638 solvent extraction Methods 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 238000004809 thin layer chromatography Methods 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- 241000178564 Agrobacterium aurantiacum Species 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- 101710095468 Cyclase Proteins 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000195634 Dunaliella Species 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 240000000785 Tagetes erecta Species 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 244000309464 bull Species 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 125000001475 halogen functional group Chemical group 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000003505 mutagenic effect Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- 108020004418 ribosomal RNA Proteins 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 239000001052 yellow pigment Substances 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- AYJXHIDNNLJQDT-UHFFFAOYSA-N 2,6,6-Trimethyl-2-cyclohexene-1,4-dione Chemical compound CC1=CC(=O)CC(C)(C)C1=O AYJXHIDNNLJQDT-UHFFFAOYSA-N 0.000 description 1
- PAWQVTBBRAZDMG-UHFFFAOYSA-N 2-(3-bromo-2-fluorophenyl)acetic acid Chemical compound OC(=O)CC1=CC=CC(Br)=C1F PAWQVTBBRAZDMG-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 241000235553 Blakeslea trispora Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100433727 Caenorhabditis elegans got-1.2 gene Proteins 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241000196305 Nannochloris Species 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 241000081271 Phaffia rhodozyma Species 0.000 description 1
- 241000223252 Rhodotorula Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003674 animal food additive Substances 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- FDSDTBUPSURDBL-DKLMTRRASA-N canthaxanthin Chemical compound CC=1C(=O)CCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C FDSDTBUPSURDBL-DKLMTRRASA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 208000002458 carcinoid tumor Diseases 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000019244 cryptoxanthin Nutrition 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000002036 drum drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000000640 hydroxylating effect Effects 0.000 description 1
- FBAFATDZDUQKNH-UHFFFAOYSA-M iron chloride Chemical compound [Cl-].[Fe] FBAFATDZDUQKNH-UHFFFAOYSA-M 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000000622 liquid--liquid extraction Methods 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000003264 margarine Substances 0.000 description 1
- 235000013310 margarine Nutrition 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 125000001695 zeaxanthin group Chemical group 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
- A23L5/44—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives using carotenoids or xanthophylls
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B61/00—Dyes of natural origin prepared from natural sources, e.g. vegetable sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the present invention relates to zeaxanthin, ⁇ -carotene, lycopene, and the like, which are useful as natural yellow pigments, natural red pigments, and antioxidants for feed, food, cosmetics, pharmaceuticals, and the like.
- the present invention relates to a microbial production method of a carotenoid mixture containing
- Zeaxanthin is contained in various plants such as corn and is added to feeds as a natural yellow pigment, and is used for improving the color tone of egg yolk, meat and epidermis of poultry such as -Petori and as a coloring agent for foods. known. It also has a strong antioxidant effect (Fisheries Science, 62 (1), 134-137, 1996), and has been reported to have an antitumor cancer effect ⁇ ! Pull (Biol. Pharm. Bui 1., 18 (2 ), 227-233, 1995). Zeaxanthin, together with rutin, is known to be present in the retina and lens, and is involved in maintaining eye health (FOOD Style 21, 3 (3), 50-53, 1999).
- Zeaxanthin is also useful as a material for health foods, cosmetics and pharmaceuticals.
- ⁇ cryptoxanthin is contained in citrus fruits and is known to have an antitumor effect (Biol. Pharm. Bull., 18 (2), 227-233, 1995), and is used as a food material and feed compound .
- 8-Carotene has provitamin A action and antioxidant action, and is widely used as feed additive, food additive, natural colorant, etc.
- Zeaxanthin is produced by a chemical synthesis method using an optically active hydroxyketone obtained by asymmetric reduction of oxoisophorone as a raw material (Pure Appl. Chem., 63 (1), 45, 1991), and corn seeds.
- a method of extracting force biological dye, 1974, Asakura Shoten
- a method of extracting marigold power is also known (JP-A-8-092205), but the main component of the carotenoid derived from marigold is rutin and the content of zeaxanthin is low.
- microorganisms produced include Spirulina algae (Japanese Patent Application Laid-Open No.
- Nannochloris microalgae Japanese Patent Application Laid-Open No. 7-59558
- Bacteria of the genus Flexipactor Japanese Patent Application Laid-Open No. 5-228978
- Kaihei 5-49497 Bacteria belonging to the genus Flavata (Carote) noids, in Microbial Technology, 2nd edn, Vol. 1, 529—544, New
- ⁇ -Ikkiriten is a natural yellow carotenoid contained in green-yellow vegetables such as carrots and is widely used as a coloring agent for foods such as butter and margarine. Also provitamins
- ⁇ It is active and is an important nutrient for humans. It is known to have an antioxidant effect (Fisheries Science, 62 (1), 134-137, 1996), and antitumor and anticancer effects have been reported (Biol. Pharm. Bull., 18 (2), 227-233, 1995). These physiological effects j8-carotene is useful not only as a coloring agent but also as a functional material for feed, food, cosmetics and pharmaceuticals.
- yeast Phaffia rhodozyma Japanese Patent Laid-Open No. 5-168465
- yeast of the genus Rhodotorula Japanese Patent Laid-Open No. 6-22748
- bacteria Agrobacterium aurantiacum Agrobacterium aurantiacum.
- FERM BP-4283 a new genus of bacteria strain E-396 (FERM BP-4283) (JP-A-7-79796, JP-A-8-9964, U.S. Pat. No. 5,607,839; U.S. Pat. No. 5,858,761) Known!
- Lycopene is a natural red carotenoid contained in tomato and is useful as a food coloring. It also has a strong antioxidant action (Arch. Biochem. Biophys., 271, 532, 1989) and is known to inhibit the low-density lipoprotein oxidase associated with arteriosclerosis (Nutr. Metab. Cordiovasc., Dis 7, 433, 1997), and has been reported to suppress the growth of cancer cells (J. Natl. Cancer Inst. 91, 313, 1999). These physiological effects Lycopene is useful as a feed, food, cosmetic and pharmaceutical ingredient.
- a method for producing lycopene a method of chemically synthesizing linalool or gera-ol as a raw material (JP-A-2001-39943) and a method of separating and purifying from tomato (JP-A-2002-193850) are known.
- microorganisms producing lycopene include Donariella algae (JP-A-2001-161391), chlorella algae (JP-A-2000-152778), and bacteria belonging to the genus Rhodopactor (JP-A-8-239658).
- E-396 strain known as a carotenoid compound-producing bacterium
- a method has been established to produce a carotenoid-containing compound containing astaxanthin at a high concentration on an industrial scale.
- the ratio of zeaxanthin, j8-Rikuten and lycopene in the total rotenoid produced is low! ,.
- the present invention provides the following inventions.
- Mutagenesis is induced in an astaxanthin-producing microorganism in which the nucleotide sequence of DNA corresponding to 16S ribosomal RNA is substantially homologous to the nucleotide sequence of SEQ ID NO: 1,
- the ratio (% by mass) of the zeaxanthin to the total amount of rotenoid production is higher than that of the parent strain
- the mutant strain is selected to obtain a zeaxanthin-producing microorganism
- the culture power obtained by culturing the zeaxanthin-producing microorganism is zeaxanthin or zeaxanthin.
- a method for producing zeaxanthin or a zeaxanthin-containing carotenoid mixture comprising collecting a carotenoid mixture containing zeaxanthin.
- a mutant strain in which the ratio (mass%) of ⁇ -Ichiguchi ten to total power rotenoid production is higher than that of the parent strain was selected to obtain j8-Rikiguchi ten producing microorganisms, and the j8-Rikiguchi ten producing microorganisms were isolated.
- Contains ⁇ -Ichi-Rokuten or ⁇ -IchiRoku-Ten from the culture obtained by culturing A method for producing a carotenoid mixture comprising a ⁇ -strengthene or a ⁇ -strength, comprising collecting a carotenoid mixture to be treated.
- Echinenone, j8-cryptoxanthin, 3-hydroxyechinenone, asteroidenone, canthaxanthin, zeaxanthin, adonirubin, adonixanthin, and astaxanthin produced by an 8-carotene-producing microorganism The method according to any one of the above (7) to (11), wherein the ratio of each to the total amount of rotenoid production is! / ⁇ deviation of less than 20% by mass.
- the carotenoid-producing microorganism is selected from E-396 strain (FERM BP-4283) and its mutant strain, and A-581-1 strain (FERM BP-4671) and its mutant strain (7) — (12) The method described in any of the above.
- the nucleotide sequence of the DNA corresponding to the 16S ribosomal RNA is substantially homologous to the nucleotide sequence of SEQ ID NO: 1, and ⁇ -ryokuten, echinenone,
- the ratio of lycopene produced by inducing mutations to total rotenoid production (% by mass) Is higher than that of the parent strain, obtaining a lycopene-producing microorganism by selecting a mutant strain, and collecting a lycopene or a lycopene-containing carotenoid mixture from a culture obtained by culturing the lycopene-producing microorganism.
- lycopene or a carotenoid mixture containing lycopene.
- Specific examples of the astaxanthin or carotenoid-producing microorganism having a sequence substantially homologous to the above sequence include E-396 strain (FERM BP-4283) and A-581-1 strain (FERM). BP-4671), and various mutants obtained by mutating the E-396 strain or the A-581-1 strain, and two closely related species thereof.
- SEQ ID NO: 1 D The NA nucleotide sequence corresponds to the ribosomal RNA of E-396 strain, and the DNA nucleotide sequence of SEQ ID NO: 2 corresponds to the ribosomal RNA of A-581-1 strain.
- the nucleotide sequence homology of the 16S ribosomal RNA of the E-396 strain and the A-581-1 strain was 99.4%, which proved to be extremely closely related. Therefore, these strains form a group as carotenoid-producing bacteria.
- the parent strain of the mutation used in the method of the present invention includes E-396 strain and A-581-1 strain, a mutant strain of E-396 strain or A-581-1 strain, and closely related species of these strains.
- the DNA base sequence corresponding to 16S ribosomal RNA is defined as a astaxanthin or carotenoid-producing bacterium having 98% or more homology with the base sequence of SEQ ID NO: 1.
- the method for mutating an astaxanthin-producing microorganism is not particularly limited as long as it induces the mutation.
- chemical methods using a mutagen such as N-methyl-N'-two-trough N-nitrosogazine (NTG), ethyl methanesulfonate (EMS), physical methods such as ultraviolet irradiation, X-ray irradiation, etc.
- Biological methods such as gene recombination and transposons can be used.
- This mutation treatment may be performed once or, for example, by obtaining a mutant of an astaxanthin-producing microorganism by this mutation treatment and further mutating the mutant, two or more mutation treatments are performed as described above.
- the mutant strain can be cultured, for example, by culturing it in a medium containing a component necessary for growth of a producing bacterium and producing a carotenoid compound.
- the culture method may be any method such as shaking culture of a test tube or a flask, or aeration and agitation culture.
- the carotenoid compound can be analyzed by any method capable of separating and detecting the carotenoid compound. For example, high-performance liquid chromatography, thin-layer chromatography, paper chromatography and the like can be used.
- the zeaxanthin-producing microorganism is obtained by selecting a mutant having a high zeaxanthin production ratio with respect to the total amount of rotenoid, and the total amount of rotenoid referred to in the present specification is defined as astaxanthin.
- Taxanthin Canthaxanthin, adonixanthin, -Rikokuten, echinenone, zeaxanthin, j8-cryptoxanthin, 3-hydroxyecenone, asteroidenone, ad-rubin and the like.
- Astaxanthin-producing microorganisms such as strain E-396 include astaxanthin, canthaxanthin, adonixanthin, j8-ryokuten, echinenone, zeaxanthin, j8-cryptoxanthin, 3-hydroxyexeninone, and axyxanthin. It produces various carotenoid compounds such as steroidenone and ad-rubin simultaneously. Therefore, the ratio of zeaxanthin production to the total amount of rotenoids is low, usually about 0-10% by mass.
- mutations are induced in an astaxanthin-producing microorganism, and a mutant strain in which the ratio of zeaxanthin to the total amount of rotenoid produced is particularly high is selected.
- the criteria for selection are zeaxane It is necessary that the production ratio of tin is at least higher than the production ratio of zeaxanthin in the parent strain before mutation, and the production ratio of zeaxanthin is preferably 20% by mass or more, more preferably 20% by mass or more, based on the total amount of rotenoid produced.
- a mutant strain of 40% by mass or more, more preferably 60% by mass or more, is selected.
- the parent strain for the mutation used in the present invention is that the DNA base sequence corresponding to 16S ribosomal RNA has 98% or more homology with the base sequence shown in SEQ ID NO: 1, and echinenone, j8-cryptoxanthin , 3-hydroxyechinenone, asteroidenone, canthaxanthin, zeaxanthin, adironrubin, adonixanthin, and astaxanthin, a power defined as a carotenoid-producing microorganism that produces at least one carotenoid compound, preferably production Total power of the total amount of canthaxanthin and echinenone to be produced A carotenoid-producing microorganism whose ratio to the amount of rotenoid production is 50% by mass or more, or the total power of the total amount of zeaxanthin and ⁇ cryptoxanthin produced to produce rotenoid A carotenoid-producing microorganism having a ratio of at least 50% by mass is used.
- the ratio of the total amount of canthaxanthin and echinenone to the total amount of rotenoid production is 70% by mass or more, or the total amount of rotenoid production of the total amount of zeaxanthin and j8-cryptoxanthin to be produced.
- a carotenoid-producing microorganism having a ratio to 70% by mass or more is used.
- the total amount of rotenoid referred to in the present specification refers to ⁇ -carotene, echinenone, j8-cryptoxanthin, 3-hydroxyechinenone, asteroidenone, canthaxanthin, zeaxanthin, adilrubin, adonixanthin, astaxanthin and the like. 1 shows the total amount of carotenoid conjugate.
- both ends of lycopene are cyclized to form ⁇ -lactate, and j8-carotene is further modified with a ketoenzyme and a hydroxylase at the 6-membered ring at each end. It is estimated that this results in the production of canthaxanthin, zeaxanthin, and astaxanthin (see Figure 1).
- the present inventors have compared the use of a microorganism producing a high ratio of astaxanthin as a parent strain of a mutant with a microorganism producing a high ratio of canthaxanthin and echinenone, or zeaxanthin and j8-crypto.
- a microorganism that produces a high ratio of xanthine as a parent strain, we found that the probability of obtaining a j8-ryokuten-producing microorganism was dramatically improved. This phenomenon can be explained as follows.
- a carotenoid-producing microorganism that produces a high ratio of astaxanthin has both an enzyme for hydroxylating ⁇ -lactate and an enzyme for keto-formation.
- the ability to delete both enzymes The microorganism with a high ratio of the total amount of canthaxanthin and echinenone is a microorganism lacking hydroxylase, so it is sufficient to delete only the ketoenzyme by mutation.
- a microorganism having a high ratio of the total amount of zeaxanthin and ⁇ -cryptoxanthin is a microorganism deficient in ketoenzyme, so that only the hydroxylase needs to be eliminated.
- Microorganisms and microorganisms with a high ratio of the total amount of zeaxanthin and j8-cryptoxanthin may be those that have the properties of a wild strain originally, but those that have the ability to produce astaxanthin by mutation, etc. Good.
- the method for mutating a carotenoid-producing microorganism there is no particular limitation as long as it does.
- a chemical method using a mutagen such as N-methyl-N, one-two-row N-nitrosguanidine (NTG), ethyl methanesulfonate (EMS), a physical method such as ultraviolet irradiation, X-ray irradiation, and a gene.
- Biological methods such as recombination and transposons can be used.
- This mutation treatment may be performed once or, for example, if a mutant of a carotenoid-producing microorganism is obtained by this mutation treatment, and this is further suddenly mutagenized! / Let's go.
- the ratio (% by mass) of ⁇ -carotene to the total amount of rotenoids produced was higher than that of the parent strain.
- Select mutant strains to obtain j8-carotene-producing microorganisms For this purpose, a colony may be formed on a solid medium after the mutagenesis treatment, and a colony may be obtained at random. However, a colony of a ⁇ -carotene-producing microorganism often exhibits a yellow-orange color. By selecting a colony exhibiting such a color, j8-carotene-producing microorganisms (mutants) can be efficiently selected. By including this step, the probability of obtaining a mutant having a high ratio of j8-ryokuten to the total amount of rotenoid produced is greatly improved.
- each mutant colony selected as described above is cultured by a conventional method, and after completion of the culture, the carotenoid-conjugated product contained in the culture solution of each mutant is analyzed, and ⁇ ⁇ Mutants with a high production ratio of lipstick can be selected.
- the cultivation of the mutant strain can be performed, for example, by culturing it in a medium containing a component necessary for growth of a producing bacterium and producing a carotenoid compound.
- the culture method may be any method such as shaking culture of a test tube or a flask, or aeration and agitation culture.
- the carotenoid compound can be analyzed by any method capable of separating and detecting the carotenoid compound. For example, high-performance liquid chromatography, thin-layer chromatography, paper chromatography and the like can be used.
- the third / 3-strength ten-producing microorganism is obtained by selecting a mutant strain having a high ratio of j8-carotene to the total amount of rotenoid.
- Carotenoid-producing microorganisms such as E-396 strains include astaxanthin, canthaxanthin, adonixanthin, ⁇ -carotene, echinenone, zeaxanthin, j8-cryptoxanthin, and 3-hydroxyechineno.
- the ratio of j8-force mouth ten to the total amount of rotenoid is low, usually about 0 to 20% by mass.
- a mutation is induced in a carotenoid-producing microorganism, and a mutant having a particularly high ratio of j8-ryokuten to the total amount of rotenoid produced is selected.
- a mutant strain in which the ratio of ⁇ -Ichiguchi ten is preferably 50% by mass or more, more preferably 70% by mass or more, and still more preferably 90% by mass or more is selected.
- carotenoid biosynthesis is performed by modifying the 6-membered ring at both ends of the j8-ryokuten with a ketoenzyme and a hydroxylase, as described above, so that canthaxanthin, zeaxanthin, and astaxanthin. It is presumed that these are generated (see Figure 1).
- the ketoenzyme and hydroxylase are incompletely deficient, the production ratio of j8-ryokuten will increase, and echinenone, j8-cryptoxanthin, 3-hydroxyechinenone, asteroidenone, canthaxane It is estimated that the ratio of carcinoid, zeaxanthin, adonolinevin, adonixanthin and astaxanthin to the total carotenoid production is reduced.
- Another effective means for selecting j8-Rikiten ten-producing microorganisms from mutant strains is echinenone, j8-cryptoxanthin, 3-hydroxyechinenone, asteroidenone, cantaxanthin,
- a method of selecting based on the fact that the ratio of zeaxanthin, addirubin, adonixanthin, and astaxanthin to the total amount of rotenoids is low can be used. Selection can be made on the basis that the ratio of each of the aforementioned compounds to the total power rotenoid is less than 20% by mass, more preferably less than 10% by mass, and even more preferably less than 5% by mass.
- the parent strain of the mutation used in the present invention has a DNA base sequence corresponding to 16S ribosomal RNA having 98% or more homology with the base sequence set forth in SEQ ID NO: 1 and
- a carotenoid-producing microorganism that produces at least one selected carotenoid compound Is defined as Ability to use a wild-type strain that produces at least one of the above carotenoids as a parent strain of a mutant
- By artificial mutagenesis for example, a mutant strain with improved astaxanthin productivity or a mutant with improved canthaxanthin productivity Strains, mutants with improved zeax
- each mutant colony selected as described above is cultured by a conventional method, and after completion of the culture, the carotenoid-conjugated product contained in the culture solution of each mutant is analyzed, and lycobe If the production ratio of the protein is high, a mutant strain can be selected.
- the mutant strain can be cultured, for example, by culturing it in a medium containing a component required for growing a producing bacterium and producing a carotenoid compound.
- the culture method may be any method such as shaking culture of a test tube or a flask, or aeration and agitation culture.
- the carotenoid compound can be analyzed by any method capable of separating and detecting the carotenoid compound. For example, high-performance liquid chromatography, thin-layer chromatography, paper chromatography and the like can be used.
- the lycopene-producing microorganism is obtained by selecting a mutant strain having a high ratio to the total amount of lycopene rotenoid, and the total amount of lycopene as referred to in the present specification is lycopene, j8- It indicates the total amount of carotenoid compounds such as Rikokuten, echinenone, j8-cryptoxanthin, 3-hydroxyecenone, asteroidenone, canthaxanthin, zeaxanthin, adilrubin, adnixanthin, and astaxanthin.
- carotenoid compounds such as Rikokuten, echinenone, j8-cryptoxanthin, 3-hydroxyecenone, asteroidenone, canthaxanthin, zeaxanthin, adilrubin, adnixanthin, and astaxanthin.
- Carotenoid-producing microorganisms such as E-396 strain include astaxanthin, canthaxanthin, adonixanthin, —Rikakuten, echinenone, zeaxanthin, j8-cryptoxanthin, 3-hydroxyxynenone, and asteroy. Since various carotenoid compounds such as denone and ad-rubin are produced simultaneously, the ratio of lycopene to the total amount of rotenoids is low, usually about 0-5% by mass.
- mutants are selected in which the ratio of produced lycopene to the total amount of rotenoids is particularly high.
- the lycopene production ratio is at least higher than the lycopene production ratio of the parent strain before mutation, but the lycopene production ratio is preferably based on the total amount of rotenoid produced.
- both ends of lycopene are cyclized to form j8-ryokuten, and the j8-ryokuten is further modified with a ketoenzyme and hydroxylase at the six-membered ring at each end.
- canthaxanthin, zeaxanthin, and astaxanthin are generated (see Fig. 1).
- Another effective means for selecting neutral lycopene producing microorganisms of the mutant strains is as follows: / 3 power roten, echinenone, j8-cryptoxanthin, 3-hydroxyechinenone, asteroidenone,
- a method can be used in which selection is made based on the low ratio of each of the taxontaxin, zeaxanthin, adironrubin, adonixanthin, and astaxanthin to the total amount of rotenoids. Selection can be made on the basis that the ratio of each of the aforementioned compounds to the total power rotenoid is less than 20% by mass, more preferably less than 10% by mass, and even more preferably less than 5% by mass.
- the zeaxanthin-producing mutant, the j8-ryokuten-producing mutant or the lycopene-producing mutant selected as described above are cultured as described below, and the target carotenoid compound is collected.
- each of the above mutant microorganisms is cultured to collect zeaxanthin, j8-ryokuten, lycopene, or a carotenoid mixture containing them.
- the method of culturing the mutant microorganism may be any method as long as it produces the target carotenoid compound.
- the following method can be employed. That is, a medium containing a carbon source, a nitrogen source, an inorganic salt and, if necessary, special required substances (eg, vitamins, amino acids, nucleic acids, etc.) necessary for growth of the producing bacterium is used.
- the carbon source examples include sugars such as glucose, sucrose, funolectose, trenoperose, mannose, mannitol, and manoletose, organic acids such as acetic acid, fumaric acid, cunic acid, propionic acid, malic acid, and malonic acid, ethanol, propanol, butanol, Alcohols such as pentanole, hexanol and isobutanol are exemplified.
- the addition ratio varies depending on the type of carbon source, but is usually 100 g / L, preferably 2-50 g / L of the medium.
- the nitrogen source for example, nitric acid Lium, ammonium nitrate, ammonium chloride, ammonium sulfate, ammonium phosphate
- the proportion of added calories varies depending on the type of nitrogen source, but is usually 0.1 to 20 g, preferably 1 to 10 g per liter of medium.
- inorganic salts potassium dihydrogen phosphate, dipotassium hydrogen phosphate, disodium hydrogen phosphate, magnesium sulfate, magnesium chloride, iron sulfate, iron chloride, manganese sulfate, manganese salt, zinc sulfate, zinc chloride, copper sulfate , Calcium carbonate, calcium carbonate, sodium carbonate and the like.
- the addition ratio varies depending on the type of inorganic salt. Usually, it is 0.1 to 10 g per liter of medium.
- Specially required substances include vitamins, nucleic acids, yeast extract, peptone, meat extract, malt extract, corn steep liquor, dried yeast, soybean meal, soybean oil, olive oil, corn oil, flax oil, etc. Species or two or more are used. The addition ratio varies depending on the type of special required substance, but it is usually 0.1 Olmg to 100 g per 1 L of medium.
- the pH of the medium is adjusted to 2-12, preferably 6-9.
- the culture condition is a temperature of 10-70 ° C, preferably 20-35 ° C, and shaking culture or aeration-agitation culture is usually performed for 1 to 20 days, preferably 2 to 9 days.
- the operation of removing the water from the culture solution obtained by the above method is performed.
- the amount of water required to remove the culture solution depends on the state of the pigment content of the culture solution, etc.
- the filtration can be performed by a usual filtration method, a centrifugation method or the like. If it is necessary to further remove water, a method of drying the precipitate can be used. Examples of the drying method include ordinary spray drying, drum drying, freeze drying and the like.
- the content of the target carotenoid compound can be increased by extraction.
- the culture solution itself may be used, or a precipitate after filtration or a dried product thereof may be used.
- the extraction method include solvent extraction and supercritical carbon dioxide extraction.
- the organic solvent used for solvent extraction is not particularly limited, and may be a water-soluble organic solvent or a water-insoluble organic solvent.
- water-soluble organic solvents include tetrahydrofuran, pyridine, dioxane, cyclohexanone, cyclohexanol, methanol, Examples include ethanol, isopropanol, acetone, ethyl methyl ketone, dimethylformamide, and dimethyl sulfoxide.
- the extraction solvent may be used as a mixture of two or more kinds, or may be used as a mixture with water.
- the obtained extract can be used as a product by removing the solvent by concentration under reduced pressure or the like. If necessary, it may be deodorized or suspended in vegetable oil.
- the carotenoid compound is purified by a conventional purification means such as liquid-liquid extraction using a combination of two or more solvents, column chromatography, and the like.
- the carotenoid conjugate may be precipitated by concentrating or cooling the extract or eluate containing the compound, or by adding a poor solvent.
- Cultured precipitates, dried sediments, extracts, purified extracts, etc. containing zeaxanthin, j8-ryokuten or lycopene obtained by the above method are used as feed ingredients, food materials, cosmetic materials, and pharmaceutical materials. Etc. can be used.
- FIG. 1 is a diagram showing a biosynthetic pathway of a carotenoid compound.
- E-396 strain (FERM BP-4283) was mutagenized with 200 mg ZL of NTG (N-methyl-N, 1-toro-N-nitrosogazine) at 28 ° C for 30 minutes. . 6 ml of the medium having the composition shown in Table 1 was placed in a test tube having an inner diameter of 18 mm, and sterilized with steam at 121 ° C for 15 minutes to prepare a test tube medium. 200 yellow-orange mutant colonies were selected, and each was inoculated with one platinum loop in a test tube medium and subjected to reciprocal shaking culture at 330 rpm for 4 days at 28 ° C. It was.
- the E-396 strain (FERM BP-4283) was mutagenized with 200 mg ZL of NTG (N-methyl-N-tro-N-trosoguanidine) at a temperature of 28 ° C for 30 minutes. 6 ml of the medium having the composition shown in Table 1 was placed in a test tube having an inner diameter of 18 mm, and sterilized with steam at 121 ° C for 15 minutes to prepare a test tube medium. 1,500 mutant colonies were randomly selected, and one platinum loop was inoculated in a test tube medium and reciprocally shaken at 330 rpm for 4 days at 28 ° C. Next, this culture was centrifuged, and the obtained carotenoid conjugate of the cells was analyzed by high performance liquid chromatography.
- One strain in which the ratio of adonirubin, adonixanthin and astaxanthin to the total carotenoid production was less than 10% by mass was obtained.
- Table 4 shows the results of analysis of the carotenoid conjugate of this strain.
- the E-396 strain (FERM BP-4283) was subjected to mutation treatment with NTG, and a red-colored dark mouth was selected to obtain a mutant Y-559 strain having improved astaxanthin productivity.
- This Y-559 strain was further mutated with 150 mg ZL of NTG.
- 6 ml of a medium having the composition shown in Table 1 was placed in a test tube having an inner diameter of 18 mm, and sterilized with steam at 121 ° C for 15 minutes to prepare a test tube medium.
- 350 mutant colonies exhibiting yellow-orange color were selected, and one platinum loop was inoculated into a test tube medium, and reciprocating shaking culture at 330 rpm was performed at 28 ° C for 5 days.
- A—581—1 strain (FERM BP—4671) was mutated by irradiating it with a UV lamp. 6 ml of a medium having the composition shown in Table 1 was placed in a test tube having an inner diameter of 18 mm, and sterilized by steam at 121 ° C for 15 minutes to prepare a test tube medium. 280 mutant colonies exhibiting yellow-orange color were selected, and one platinum loop was inoculated into each test tube medium, and cultured at 28 ° C for 4 days with reciprocating shaking at 330 rpm. Next, this culture was centrifuged, and the resulting cells were analyzed for carotenoid compounds by high performance liquid chromatography.
- the E-396 strain (FERM BP-4283) was mutated with NTG, and orange colonies were selected to obtain a mutant CA-22 strain with improved canthaxanthin productivity.
- This CA-22 strain was further mutated with 200 mg ZL of NTG.
- 6 ml of a medium having the composition shown in Table 9 was placed in a test tube having an inner diameter of 18 mm, and sterilized with steam at 121 ° C. for 15 minutes to prepare a test tube medium. Eighty-one orange-colored mutant colonies were selected, and one platinum loop was inoculated in a test tube medium and reciprocally shaken at 330 rpm for 5 days at 28 ° C.
- the E-396 strain (FERM BP-4283) was mutated with NTG, and a yellow colony was selected to obtain a mutant ZE-7 strain having improved zeaxanthin productivity.
- the ZE-7 strain was further mutated with 150 mg ZL of NTG.
- 6 ml of the medium having the composition shown in Table 9 was placed in a test tube having an inner diameter of 18 mm, and sterilized with steam at 121 ° C for 15 minutes to prepare a test tube medium.
- Sixty yellow-orange mutant colonies were selected, and each was inoculated with one platinum loop in a test tube medium and reciprocally shaken at 330 rpm for 5 days at 28 ° C.
- A—581—1 strain (FERM BP—4671) was mutated by irradiating it with a UV lamp. 6 ml of a medium having the composition shown in Table 9 was placed in a test tube having an inner diameter of 18 mm, and sterilized by steam at 121 ° C for 15 minutes to prepare a test tube medium. 3,000 mutant colonies showing yellow color were selected, and one platinum loop was inoculated in each test tube medium, and reciprocating shaking culture at 330 rpm was performed at 28 ° C for 4 days. Next, the culture was centrifuged and the resulting cells were analyzed for carotenoid compounds by high performance liquid chromatography.
- Echinenone, j8-cryptoxanthin, 3-hydroxyechinenone, asteroidenone, canthaxanthin , Zeaxanthin, adironrubin, adonixanthin, and astaxanthin have a ratio to the total amount of rotenoid production!
- One strain having a deviation of less than 20% by mass was obtained.
- Table 16 shows the results of carotenoid compound analysis of this strain.
- Table 17 shows the results of analysis of carotenoid compounds in the culture of 581-1 strain.
- E-396 strain (FERM BP-4283) was mutagenized with lOOmgZL of NTG (N-methyl-N, 1-toro-N-ditrosogazine) at 28 ° C for 30 minutes. . 6 ml of the medium having the composition shown in Table 18 was placed in a test tube having an inner diameter of 18 mm, and sterilized with steam at 121 ° C. for 15 minutes to prepare a test tube medium. Sixty pink and reddish purple mutant colonies were selected, and each was inoculated with one platinum loop in a test tube medium and reciprocated with shaking at 330 rpm at 28 ° C for 4 days.
- composition amount g / L yeast extract 20 Pepubokun 5 Sucrose 50 KH 2 P0 4 1. 5 N a 2 HP 0 4 ⁇ 1 o 3. 8 Mg 50 4 ⁇ 7 H 2 0. 5 F e 3 O 4 ⁇ 7 H 2 0. 0 1 C a C 1 2 ⁇ 2 H 2 ooo 2 0. 0 1
- the E-396 strain (FERM BP-4283) was subjected to mutation treatment with NTG, and a red-colored dark mouth was selected to obtain a mutant Y-559 strain having improved astaxanthin productivity.
- This Y-559 strain was further mutated with 150 mg ZL of NTG.
- 6 ml of a medium having the composition shown in Table 18 was placed in a test tube having an inner diameter of 18 mm, and steam-sterilized at 121 ° C for 15 minutes to prepare a test tube medium.
- Eighty pink-reddish purple mutant colonies were selected, and each was inoculated with one platinum loop in a test tube medium and reciprocally shaken at 330 rpm for 5 days at 28 ° C.
- the E-396 strain (FERM BP-4283) was mutated with NTG, and orange colonies were selected to obtain a mutant CA-22 strain with improved canthaxanthin productivity.
- This CA-22 strain was further mutated with 200 mg ZL of NTG.
- 6 ml of the medium having the composition shown in Table 18 was placed in a test tube having an inner diameter of 18 mm, and sterilized with steam at 121 ° C for 15 minutes to prepare a test tube medium. Sixty pink-reddish purple mutant colonies were selected, and one platinum loop was inoculated in a test tube medium and reciprocally shaken at 330i: pm for 5 days at 28 ° C.
- the culture is then centrifuged Then, the carotenoid-conjugated product of the obtained cells was analyzed by high performance liquid chromatography. As a result, one strain showing the ratio of lycopene to total rotenoid production of 0% by mass or more was obtained.
- the results of analysis of the carotenoid ligated product of this strain are shown in Table 24, and the results of analysis of the carotenoid compounds of the CA-22 strain cultured under the same conditions as described above are shown in Table 25 for comparison.
- the E-396 strain (FERM BP-4283) was mutated with NTG, and a yellow colony was selected to obtain a mutant ZE-7 strain having improved zeaxanthin productivity.
- the ZE-7 strain was further mutated with 150 mg ZL of NTG. 6 ml of the medium having the composition shown in Table 18 was placed in a test tube having an inner diameter of 18 mm, and sterilized with steam at 121 ° C for 15 minutes to prepare a test tube medium. Pink-reddish purple Eighty mutant colonies showing color were selected, and each was inoculated with one platinum loop in a test tube medium and reciprocally shaken at 330 rpm for 5 days at 28 ° C.
- A—581—1 strain (FERM BP—4671) was mutated by irradiating it with a UV lamp. 6 ml of a medium having the composition shown in Table 18 was placed in a test tube having an inner diameter of 18 mm, and steam-sterilized at 121 ° C for 15 minutes to prepare a test tube medium. 100 mutant pink colonies were selected and One platinum loop was inoculated into each test tube medium, and reciprocal shaking culture at 330 rpm was performed at 28 ° C for 4 days. Next, the culture was centrifuged, and the resulting carotenoid conjugate was analyzed by high-performance liquid chromatography.
- the method of the present invention is useful for the production of zeaxanthin, j8-ryokuten and lycopene, which are useful as dyes and antioxidants, and carotenoid mixtures containing them as a main component.
- the present invention provides a method for producing zeaxanthin, ⁇ -one-strengthene, or lycopene, which is inexpensive, can be stably supplied, and has high safety.
- some of the zeaxanthin, / 3 Ichirokuten or lycopene-producing mutant strains contain zeaxanthin, j8-rihokuten or lycopene as a main product and a by-product as a byproduct.
- zeaxanthin, j8-rihokuten or lycopene as a main product and a by-product as a byproduct.
- other carotenoid compounds such as j8-cryptoxanthin and ⁇ or j8-carotene may be produced at the same time, and the present invention is also useful as a method for efficiently producing a mixture of these carotenoids.
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT04787716T ATE557097T1 (de) | 2003-09-17 | 2004-09-08 | Verfahren zur herstellung von zeaxanthin und beta-cryptoxanthin |
ES04787716T ES2387674T3 (es) | 2003-09-17 | 2004-09-08 | Proceso para producir zeaxantina y beta-criptoxantina |
AU2004274750A AU2004274750B2 (en) | 2003-09-17 | 2004-09-08 | Process for producing carotenoid compound |
EP04787716A EP1676925B1 (en) | 2003-09-17 | 2004-09-08 | Process for producing zeaxanthin and beta-cryptoxanthin |
US10/571,902 US7745170B2 (en) | 2003-09-17 | 2004-09-08 | Process for producing carotenoid compound |
CA002539069A CA2539069C (en) | 2003-09-17 | 2004-09-08 | Process for producing carotenoid compound |
DK04787716.2T DK1676925T3 (da) | 2003-09-17 | 2004-09-08 | Fremgangsmåde til produktion af zeaxanthin og beta-cryptoxanthin |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003325144A JP2005087100A (ja) | 2003-09-17 | 2003-09-17 | リコペンの製造方法 |
JP2003-325130 | 2003-09-17 | ||
JP2003325130A JP2005087099A (ja) | 2003-09-17 | 2003-09-17 | β−カロテンの製造方法 |
JP2003-325104 | 2003-09-17 | ||
JP2003325104A JP4557244B2 (ja) | 2003-09-17 | 2003-09-17 | ゼアキサンチンの製造方法 |
JP2003-325144 | 2003-09-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005028661A1 true WO2005028661A1 (ja) | 2005-03-31 |
Family
ID=34381772
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/013033 WO2005028661A1 (ja) | 2003-09-17 | 2004-09-08 | カロテノイド化合物の製造方法 |
Country Status (9)
Country | Link |
---|---|
US (1) | US7745170B2 (ja) |
EP (1) | EP1676925B1 (ja) |
KR (1) | KR20060060039A (ja) |
AT (1) | ATE557097T1 (ja) |
AU (1) | AU2004274750B2 (ja) |
CA (1) | CA2539069C (ja) |
DK (1) | DK1676925T3 (ja) |
ES (1) | ES2387674T3 (ja) |
WO (1) | WO2005028661A1 (ja) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003304875A (ja) * | 2002-04-15 | 2003-10-28 | Nippon Oil Corp | カンタキサンチンの製造方法 |
EP1676888B1 (en) | 2004-11-05 | 2012-10-24 | Conservas Vegetales de Extremadura, S.A. | Method of obtaining lycopene from tomato skins and seeds |
WO2008108674A1 (en) | 2007-03-08 | 2008-09-12 | Biotrend - Inovação E Engenharia Em Biotecnologia, Sa | Production op high- purity carotenoids by fermenting selected bacterial strains |
ES2330602B1 (es) * | 2008-03-19 | 2010-09-30 | Vitatene, S.A | Metodo de produccion de fitoeno y/o fitoflueno, o mezclas de carotenoides con alto contenido en los mismos. |
KR101392066B1 (ko) * | 2008-10-17 | 2014-05-07 | 제이엑스 닛코닛세키에너지주식회사 | 카로테노이드의 발효법 |
JP5155898B2 (ja) | 2009-01-30 | 2013-03-06 | Jx日鉱日石エネルギー株式会社 | カロテノイドの分離法 |
JP5149837B2 (ja) | 2009-02-27 | 2013-02-20 | Jx日鉱日石エネルギー株式会社 | カロテノイドの製造方法 |
CN103038358B (zh) * | 2010-03-30 | 2016-01-20 | 吉坤日矿日石能源株式会社 | 通过发酵制造玉米黄质的方法 |
JP2012025712A (ja) * | 2010-07-27 | 2012-02-09 | Jx Nippon Oil & Energy Corp | 抗不安組成物 |
JP2012170425A (ja) | 2011-02-23 | 2012-09-10 | Jx Nippon Oil & Energy Corp | ゼアキサンチン強化家禽卵 |
KR101901608B1 (ko) * | 2016-06-01 | 2018-09-28 | 한양대학교 산학협력단 | 두나리엘라 변이주 및 이를 이용한 색소 생산 방법 |
CN108913746A (zh) * | 2018-07-19 | 2018-11-30 | 威海利达生物科技有限公司 | 通过提高红法夫酵母生物量合成虾青素及测定的方法 |
JPWO2020095881A1 (ja) * | 2018-11-05 | 2021-10-07 | Eneos株式会社 | カロテノイドの血中滞留増加用組成物 |
KR102600520B1 (ko) | 2021-06-09 | 2023-11-09 | 씨제이제일제당 주식회사 | 제라닐제라닐 피로포스페이트 신타아제 변이체 및 이를 이용한 테트라테르펜, 이의 전구체, 및 테트라테르펜을 전구체로 하는 물질의 생산방법 |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0779796A (ja) * | 1993-07-22 | 1995-03-28 | Nippon Oil Co Ltd | カロチノイド色素の製造方法 |
JPH089964A (ja) * | 1994-07-04 | 1996-01-16 | Nippon Oil Co Ltd | 新規微生物 |
JPH0892205A (ja) | 1994-03-17 | 1996-04-09 | Univ America Catholic | ケン化したマリゴールドの含油樹脂からのルテインの単離、精製および再結晶法、およびその使用 |
JPH09308481A (ja) * | 1996-05-23 | 1997-12-02 | Nippon Oil Co Ltd | 色調改善剤 |
JP2001095500A (ja) * | 1999-09-30 | 2001-04-10 | Nippon Mitsubishi Oil Corp | 飼料添加用色素含有物 |
JP2001512030A (ja) * | 1997-07-29 | 2001-08-21 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム | 新規カロテノイド産生細菌種とそれを用いたカロテノイドの生産方法 |
WO2001096591A1 (fr) * | 2000-06-12 | 2001-12-20 | Nippon Mitsubishi Oil Corporation | Procede pour produire des pigments carotenoides |
JP2003304875A (ja) * | 2002-04-15 | 2003-10-28 | Nippon Oil Corp | カンタキサンチンの製造方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE790289A (fr) | 1971-10-27 | 1973-02-15 | Nestle Sa | Procede de fabrication de zeaxanthine |
US5360730A (en) | 1987-06-05 | 1994-11-01 | Universal Foods Corporation | Zeaxanthin producing strains of Neospongiococcum Excentricum |
US5607839A (en) * | 1993-07-22 | 1997-03-04 | Nippon Oil Company, Ltd. | Bacteria belonging to new genus process for production of carotenoids using same |
-
2004
- 2004-09-08 EP EP04787716A patent/EP1676925B1/en not_active Not-in-force
- 2004-09-08 US US10/571,902 patent/US7745170B2/en not_active Expired - Fee Related
- 2004-09-08 DK DK04787716.2T patent/DK1676925T3/da active
- 2004-09-08 CA CA002539069A patent/CA2539069C/en not_active Expired - Fee Related
- 2004-09-08 AU AU2004274750A patent/AU2004274750B2/en not_active Ceased
- 2004-09-08 WO PCT/JP2004/013033 patent/WO2005028661A1/ja active IP Right Grant
- 2004-09-08 KR KR1020067005252A patent/KR20060060039A/ko not_active Application Discontinuation
- 2004-09-08 ES ES04787716T patent/ES2387674T3/es active Active
- 2004-09-08 AT AT04787716T patent/ATE557097T1/de active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0779796A (ja) * | 1993-07-22 | 1995-03-28 | Nippon Oil Co Ltd | カロチノイド色素の製造方法 |
JPH0892205A (ja) | 1994-03-17 | 1996-04-09 | Univ America Catholic | ケン化したマリゴールドの含油樹脂からのルテインの単離、精製および再結晶法、およびその使用 |
JPH089964A (ja) * | 1994-07-04 | 1996-01-16 | Nippon Oil Co Ltd | 新規微生物 |
JPH09308481A (ja) * | 1996-05-23 | 1997-12-02 | Nippon Oil Co Ltd | 色調改善剤 |
JP2001512030A (ja) * | 1997-07-29 | 2001-08-21 | イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティ オブ エルサレム | 新規カロテノイド産生細菌種とそれを用いたカロテノイドの生産方法 |
JP2001095500A (ja) * | 1999-09-30 | 2001-04-10 | Nippon Mitsubishi Oil Corp | 飼料添加用色素含有物 |
WO2001096591A1 (fr) * | 2000-06-12 | 2001-12-20 | Nippon Mitsubishi Oil Corporation | Procede pour produire des pigments carotenoides |
JP2003304875A (ja) * | 2002-04-15 | 2003-10-28 | Nippon Oil Corp | カンタキサンチンの製造方法 |
Non-Patent Citations (8)
Title |
---|
BIOL. PHAIM. BULL., vol. 18, no. 2, 1995, pages 227 - 233 |
BIOL. PHARM. BULL., vol. 18, no. 2, 1995, pages 227 - 233 |
FISHERIES, SCIENCE, vol. 62, no. 1, 1996, pages 134 - 137 |
FOOD STYLE 21, vol. 3, no. 3, 1999, pages 50 - 53 |
HARKER, M. ET AL.: "Paracoccus marcusii sp. nov., an orange gram-negative coccus", INT. J SYST. BACTERIOL., vol. 48, no. 2, 1998, pages 543 - 548, XP002983667 * |
PURE APPL. CHEM., vol. 63, no. 1, 1991, pages 45 |
TRIPATHI, U. ET AL.: "Studies on Haematococcus pluvialis for improved production of astaxanthin by mutagenesis", WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY, vol. 17, no. 2, 2001, pages 143 - 148, XP002983668 * |
TSUBOKURA, A. ET AL.: "Paracoccus carotinifaciens sp. nov., a new aerobic gram-negative astaxanthin-producing bacterium", INT. J SYST. BACTERIOL., vol. 49, no. 1, 1999, pages 277 - 282, XP002962170 * |
Also Published As
Publication number | Publication date |
---|---|
KR20060060039A (ko) | 2006-06-02 |
US7745170B2 (en) | 2010-06-29 |
CA2539069C (en) | 2008-07-22 |
CA2539069A1 (en) | 2005-03-31 |
EP1676925B1 (en) | 2012-05-09 |
US20070105189A1 (en) | 2007-05-10 |
AU2004274750B2 (en) | 2007-05-17 |
ES2387674T3 (es) | 2012-09-28 |
DK1676925T3 (da) | 2012-08-27 |
EP1676925A1 (en) | 2006-07-05 |
ATE557097T1 (de) | 2012-05-15 |
AU2004274750A1 (en) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5935808A (en) | Carotenoid-producing bacterial species and process for production of carotenoids using same | |
JP4427167B2 (ja) | カロテノイド色素の製法 | |
JP4463347B2 (ja) | 飼料添加用色素含有物 | |
WO2005028661A1 (ja) | カロテノイド化合物の製造方法 | |
EP1893769B1 (en) | Biological production of zeaxanthin | |
JP3278574B2 (ja) | 色調改善剤 | |
US20050124032A1 (en) | Method of production of astaxanthin by fermenting selected strains of <I>xanthophyllomyces dendrorhous | |
JP4290559B2 (ja) | ブラケスレアトリスポラ(Blakesleatrispora)の(+)株及び(−)株を使用する混合培養物の発酵によるβ−カロテンの生産方法 | |
JP4557244B2 (ja) | ゼアキサンチンの製造方法 | |
Dufossé | Current carotenoid production using microorganisms | |
EP1496115B1 (en) | Process for obtaining canthaxanthin-producing microorganisms and for producing canthaxanthin | |
JP2005087099A (ja) | β−カロテンの製造方法 | |
JP2005087100A (ja) | リコペンの製造方法 | |
JP4486883B2 (ja) | カロテノイドを作製する方法 | |
KR100249731B1 (ko) | 아스타산틴 생산 효모 돌연변이주 및 이의 제조방법 | |
JP2023016382A (ja) | トランス型カロテノイドをシス型カロテノイドに異性化する方法 | |
Agroalimentaire et al. | CURRENT CAROTENOID PRODUCTION USING M| CROORGANISMS | |
JPH05219983A (ja) | ゼアキサンチンの生産方法 | |
KR20050046868A (ko) | 신규한 지아잔틴 생성 세균 플라보코커스 제주엔시스 및이를 사용한 지아잔틴 생산 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200480032678.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BW BY BZ CA CH CN CO CR CU CZ DK DM DZ EC EE EG ES FI GB GD GE GM HR HU ID IL IN IS KE KG KP KR LC LK LR LS LT LU LV MA MD MG MN MW MX MZ NA NI NO NZ OM PG PL PT RO RU SC SD SE SG SK SL SY TM TN TR TT TZ UA UG US UZ VC YU ZA ZM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SZ TZ UG ZM ZW AM AZ BY KG MD RU TJ TM AT BE BG CH CY DE DK EE ES FI FR GB GR HU IE IT MC NL PL PT RO SE SI SK TR BF CF CG CI CM GA GN GQ GW ML MR SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2007105189 Country of ref document: US Ref document number: 2539069 Country of ref document: CA Ref document number: 10571902 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020067005252 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004274750 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2004274750 Country of ref document: AU Date of ref document: 20040908 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004274750 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004787716 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020067005252 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004787716 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 10571902 Country of ref document: US |
|
WWG | Wipo information: grant in national office |
Ref document number: 2004274750 Country of ref document: AU |